The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kelsey Goodwin's Stock Ratings
Piper Sandler Analyst
Kelsey Goodwin is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/16/2025
Updated: Dec 16, 2025
Overall Average Return
30.2%
Smart Score
Overall Average Return Percentile
86th
Number of Ratings
30
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/18/2025 | BDTX | Buy Now | Black Diamond Therapeutic | $2.60 | 245.79% | → $9 | Assumes | → Overweight | Get Alert | |
| 11/05/2025 | DAWN | Buy Now | Day One Biopharmaceutical | $8.35 | 211.23% | $25 → $26 | Maintains | Overweight | Get Alert | |
| 10/27/2025 | NUVL | Buy Now | Nuvalent | $102.63 | 24.72% | $112 → $128 | Maintains | Overweight | Get Alert | |
| 08/19/2025 | SMMT | Buy Now | Summit Therapeutics | $17.35 | 21.04% | → $21 | Initiates | → Neutral | Get Alert | |
| 08/19/2025 | JANX | Buy Now | Janux Therapeutics | $14.70 | 185.71% | → $42 | Initiates | → Overweight | Get Alert | |
| 08/19/2025 | RVMD | Buy Now | Revolution Medicines | $77.56 | -3.3% | → $75 | Initiates | → Overweight | Get Alert | |
| 08/19/2025 | URGN | Buy Now | UroGen Pharma | $23.47 | 53.39% | → $36 | Initiates | → Overweight | Get Alert | |
| 08/19/2025 | CGON | Buy Now | CG Oncology | $37.85 | 45.31% | → $55 | Initiates | → Overweight | Get Alert | |
| 08/19/2025 | TNGX | Buy Now | Tango Therapeutics | $8.96 | 22.77% | → $11 | Initiates | → Overweight | Get Alert | |
| 08/19/2025 | NUVL | Buy Now | Nuvalent | $102.63 | 9.13% | → $112 | Initiates | → Overweight | Get Alert | |
| 08/19/2025 | BCAX | Buy Now | Bicara Therapeutics | $18.15 | 98.35% | → $36 | Initiates | → Overweight | Get Alert | |
| 06/13/2025 | URGN | Buy Now | UroGen Pharma | $23.47 | 27.82% | $15 → $30 | Maintains | Buy | Get Alert | |
| 04/29/2025 | URGN | Buy Now | UroGen Pharma | $23.47 | 70.43% | $40 → $40 | Reiterates | Buy → Buy | Get Alert | |
| 03/28/2025 | IPSC | Buy Now | Century Therapeutics | $0.63 | — | — | Reiterates | Buy → Buy | Get Alert | |
| 03/21/2025 | IPSC | Buy Now | Century Therapeutics | $0.63 | 698.72% | $12 → $5 | Maintains | Buy | Get Alert | |
| 10/29/2024 | GNLX | Buy Now | Genelux | $4.10 | 95.12% | → $8 | Initiates | → Buy | Get Alert | |
| 09/16/2024 | NUVL | Buy Now | Nuvalent | $102.63 | 2.31% | $99 → $105 | Maintains | Buy | Get Alert | |
| 08/22/2024 | URGN | Buy Now | UroGen Pharma | $23.47 | 70.43% | → $40 | Initiates | → Buy | Get Alert | |
| 07/31/2024 | MGNX | Buy Now | Macrogenics | $1.38 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 02/28/2024 | NUVL | Buy Now | Nuvalent | $102.63 | -3.54% | → $99 | Assumes | → Buy | Get Alert | |
| 09/13/2023 | TSVT | Buy Now | 2seventy bio | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 09/12/2023 | TSVT | Buy Now | 2seventy bio | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 08/15/2023 | TSVT | Buy Now | 2seventy bio | — | — | $27 → $26 | Maintains | Buy | Get Alert | |
| 06/20/2023 | ACLX | Buy Now | Arcellx | $66.33 | — | — | Maintains | Buy | Get Alert | |
| 04/24/2023 | ACLX | Buy Now | Arcellx | $66.33 | -12.56% | $45 → $58 | Maintains | Buy | Get Alert | |
| 10/31/2022 | LEGN | Buy Now | Legend Biotech | $21.59 | — | — | Initiates | → Neutral | Get Alert | |
| 10/31/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $2.25 | — | — | Initiates | → Neutral | Get Alert | |
| 10/31/2022 | IPSC | Buy Now | Century Therapeutics | $0.63 | 2296.17% | → $15 | Initiates | → Buy | Get Alert | |
| 10/31/2022 | ACLX | Buy Now | Arcellx | $66.33 | -45.73% | → $36 | Initiates | → Buy | Get Alert | |
| 10/31/2022 | TSVT | Buy Now | 2seventy bio | — | — | → $30 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved